Demographics and concomitant disorders in heart failure

被引:123
作者
Krum, H
Gilbert, RE
机构
[1] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Prevent Med, Melbourne, Vic 3181, Australia
[2] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Med, Melbourne, Vic 3181, Australia
[3] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Epidemiol, Melbourne, Vic 3181, Australia
[4] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia
关键词
D O I
10.1016/S0140-6736(03)13869-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic heart failure is an increasingly common cause of premature death and poor quality of life. Community-based epidemiological studies have provided much-needed information on the demography of chronic heart failure, providing insight into its influence on public health. In most patients, chronic heart failure Is accompanied by a range of concomitant disorders that both contribute to the cause of the disease and have a key role in its progression and response to treatment. Information on the most common comorbidities in chronic heart failure-ischaemic heart disease, hypertension, and diabetes mellitus-is presented for prespecifled subgroups in the reports of many large-scale, multicentre trials; despite their limitations, these subanalyses provide guidance in therapeutic decision-making. Similarly, because chronic heart failure is commonly an endpoint in intervention trials of both hypertension and diabetes, such studies afford important information on the prevention of chronic heart failure in these common diseases.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 162 条
[81]   Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease - The TREND (Trial on Reversing ENdothelial Dysfunction) study [J].
Mancini, GBJ ;
Henry, GC ;
Macaya, C ;
ONeill, BJ ;
Pucillo, AL ;
Carere, RG ;
Wargovich, TJ ;
Mudra, H ;
Luscher, TF ;
Klibaner, MI ;
Haber, HE ;
Uprichard, ACG ;
Pepine, CJ ;
Pitt, B .
CIRCULATION, 1996, 94 (03) :258-265
[82]   Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2 [J].
McAdam, BF ;
Catella-Lawson, F ;
Mardini, IA ;
Kapoor, S ;
Lawson, JA ;
FitzGerald, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :272-277
[83]  
McAnulty J, 1997, NEW ENGL J MED, V337, P1576
[84]   Confirmation of a heart failure epidemic: Findings from the resource utilization among congestive heart failure (REACH) study [J].
McCullough, PA ;
Philbin, EF ;
Spertus, JA ;
Kaatz, S ;
Sandberg, KR ;
Weaver, WD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (01) :60-69
[85]   NATURAL HISTORY OF CONGESTIVE HEART FAILURE - FRAMINGHAM STUDY [J].
MCKEE, PA ;
CASTELLI, WP ;
MCNAMARA, PM ;
KANNEL, WB .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (26) :1441-1446
[86]   TRENDS IN HOSPITALIZATION FOR HEART-FAILURE IN SCOTLAND 1980-1990 [J].
MCMURRAY, J ;
MCDONAGH, T ;
MORRISON, CE ;
DARGIE, HJ .
EUROPEAN HEART JOURNAL, 1993, 14 (09) :1158-1162
[87]   EVIDENCE OF OXIDATIVE STRESS IN CHRONIC HEART-FAILURE IN HUMANS [J].
MCMURRAY, J ;
CHOPRA, M ;
ABDULLAH, I ;
SMITH, WE ;
DARGIE, HJ .
EUROPEAN HEART JOURNAL, 1993, 14 (11) :1493-1498
[88]  
MEADE TW, 1992, BMJ-BRIT MED J, V304, P405
[89]   PREVALENCE OF CARDIOVASCULAR-DISEASES AMONG OLDER ADULTS - THE CARDIOVASCULAR HEALTH STUDY [J].
MITTELMARK, MB ;
PSATY, BM ;
RAUTAHARJU, PM ;
FRIED, LP ;
BORHANI, NO ;
TRACY, RP ;
GARDIN, JM ;
OLEARY, DH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (03) :311-317
[90]  
Moller M, 2001, Congest Heart Fail, V7, P146, DOI 10.1111/j.1527-5299.2001.00243.x